Intrahepatic Cholestasis of Pregnancy and Associated Adverse Maternal and Fetal Outcomes: A Retrospective Case-Control Study

Table 2

Characteristics of UDCA and non-UDCA groups.

Characteristics	Non-UDCA	UDCA	value
	41	73
Age (years)	30.00 (28.00, 34.00)	30.00 (28.00, 33.00)	0.99
Pregestational BMI (kg/m^2)	19.92 (18.59, 21.01)	19.71 (18.73, 20.76)	0.42
SBP (mmHg)	108.00 (101.50, 115.50)	107.00 (100.50, 112.00)	0.19
DBP (mmHg)	66.00 (61.50, 75.00)	66.00 (59.00, 70.00)	0.14
0hBG (mmol/l)	4.36 (4.19, 4.62)	4.33 (4.08, 4.61)	0.33
1hBG (mmol/l)	7.77 (6.75, 8.77)	7.65 (6.70, 9.17)	0.75
2hBG (mmol/l)	6.61 (6.18, 7.34)	6.49 (5.68, 7.58)	0.87
Total bile acid (μmol/l)	19.71 (12.87, 27.78)	21.66 (15.37, 28.32)	0.53
Gestational age at delivery (weeks)	38.57 (37.86, 39.29)	39.14 (38.43, 39.86)	0.01
Birth weight (g)			0.36

Data are presented as or as medians with the interquartile ranges. UDCA—patients with ICP who received UDCA; non-UDCA—patients with ICP who did not use UDCA. UDCA: ursodeoxycholic acid.